Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients
Haemophilia · 2026-05 · 32 (3) · 772-778
DOI: 10.1111/hae.70275 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Haemophilia, online erschienen am 27.03.2026. Verfasst von Michael Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gulf States Hemophilia and Thrombophilia Center Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Practice Guidelines as Topic, von Willebrand Diseases, von Willebrand Factor, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biostatistics/ Epidemiology/ Research Design (BERD), Center for Clinical and Translational Sciences (CCTS), National Center for Advancing Translational Sciences (NCATS).
Abstract (Originalsprache)
Introduction The 2021 ASH/ISTH/NHF/WFH VWD diagnosis guidelines recommend Type 1 VWD diagnoses for patients with (a) VWF
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gulf States Hemophilia and Thrombophilia Center Houston, Houston, Texas, USA.
- Department of Pediatrics, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
- Department of Internal Medicine, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
- Division of Clinical and Translational Sciences, Department of Internal medicine, McGovern Medical School, and Biostatistics/Epidemiology/Research Design (BERD) component, Center For Clinical and Translational Sciences…
ORCID-Profile: Michael Dong, Sepideh Saroukhani, Miguel Escobar, Lakshmi Srivaths
Förderung
- Biostatistics/ Epidemiology/ Research Design (BERD)
- Center for Clinical and Translational Sciences (CCTS)
- National Center for Advancing Translational Sciences (NCATS)
Zitieren
APA
Dong, M., Larson, J., Saroukhani, S., Escobar, M., & Srivaths, L. (2026). Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients. Haemophilia, 32(3), 772-778. https://doi.org/10.1111/hae.70275
Vancouver
Dong M, Larson J, Saroukhani S, Escobar M, Srivaths L. Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients. Haemophilia. 2026;32(3):772-778. doi:10.1111/hae.70275
BibTeX
@article{Dong2026,
author = {Dong, Michael and Larson, Joanna and Saroukhani, Sepideh and Escobar, Miguel and Srivaths, Lakshmi},
title = {Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients},
journal = {Haemophilia},
year = {2026},
volume = {32},
number = {3},
pages = {772--778},
doi = {10.1111/hae.70275}
}
EUVIMED